Two complementary methods for predicting peptides binding major histocompatibility complex molecules.
暂无分享,去创建一个
A Sette | C DeLisi | K Gulukota | J Sidney | C. DeLisi | J. Sidney | A. Sette | K. Gulukota
[1] S Vajda,et al. Effect of conformational flexibility and solvation on receptor-ligand binding free energies. , 1994, Biochemistry.
[2] J A Koziol,et al. Prediction of binding to MHC class I molecules. , 1995, Journal of immunological methods.
[3] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[4] R M Horton,et al. Myasthenia gravis: recognition of a human autoantigen at the molecular level. , 1993, Immunology today.
[5] Charles DeLisi,et al. Peptide docking using dynamic programming , 1996 .
[6] J. Hammer,et al. New methods to predict MHC-binding sequences within protein antigens. , 1995, Current opinion in immunology.
[7] James L. McClelland,et al. Parallel distributed processing: explorations in the microstructure of cognition, vol. 1: foundations , 1986 .
[8] C DeLisi,et al. HLA allele selection for designing peptide vaccines. , 1996, Genetic analysis : biomolecular engineering.
[9] D. Wiley,et al. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.
[10] A Sette,et al. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.
[11] Linda A. Sherman,et al. Cytolytic T-lymphocyte response to isolated class I H2 proteins and influenza peptides , 1989, Nature.
[12] Hans-Georg Rammensee,et al. MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.
[13] R J Albertini,et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. , 1990, Science.
[14] W Fierz,et al. Using a neural network to identify potential HLA‐DR1 binding sites within proteins , 1993, Journal of molecular recognition : JMR.
[15] C. DeLisi,et al. Free energy mapping of class I MHC molecules and structural determination of bound peptides , 1996, Protein science : a publication of the Protein Society.
[16] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[17] Myron M. Levine,et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites , 1987, Nature.
[18] A Sette,et al. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. , 1994, Journal of immunology.
[19] R A Good,et al. A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] Z. Nagy,et al. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.
[21] Geoffrey E. Hinton,et al. Learning internal representations by error propagation , 1986 .
[22] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[23] D. Zaller,et al. Prediction of peptide affinity to HLA DRB1*0401. , 1994, International archives of allergy and immunology.
[24] K. Parker,et al. The beta 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound. , 1992, Journal of immunology.
[25] S. H. van der Burg,et al. Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes , 1993, European journal of immunology.